Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Five- versus seven-day subcutaneous cladribine in hairy cell leukemia
2005-005998-29Phase 2Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cladribine in hairy cell leukemia (HCL) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoints: Response rate and Toxicity. Started Apr 2007; status: completed.
02
Drugs
cladribine
03
Conditions
hairy cell leukemia (HCL)
Beyond the preview
Go deeper on 2005-005998-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005998-29.